What Is Zometa?
Zometa is the trade name under which Novartis sells Zoledronic Acid. It is in the group of medicines called bisphosphonates, which alter the cycle of bone formation and breakdown in the body. Zometa is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It is also prescribed to treat osteoporosis and hypercalcemia. Zometa is administered intravenously in a 4 mg dose over 15 weeks, once every three weeks.
How Can Zometa Harm You?
Zometa can cause atypical fractures in older women and a rare condition called osteonecrosis of the jaw. Typically, women who take Zometa to treat osteoporosis are those who develop atypical fractures. Multiple myeloma patients have historically been those who have contracted osteonecrosis of the jaw. However, because women take Zometa at an earlier age, their longer use may also lead to osteonecrosis of the jaw.
How Can We Help?
The Madeksho Law Firm, P. L. L. C. will shoulder the burden of taking on the pharmaceutical industry on behalf of our clients just like it has taken on corporate wrongdoers for over 40 years. If you are prescribed a drug, it should be made safe by adequate warning, adequate research or adequate design. If a drug carries risks, the drug manufacturer should be honest about what those risks are. Call our attorneys today for a free legal consultation and we will explain your rights and how we can help. Attorneys at the Madeksho Law Firm, P. L. L. C. will do our duty to keep you informed and protected in a professional, compassionate manner.